Aiforia Technologies Plc, Press Release, April 24, 2024 at 09:00 a.m. EEST
A global leader in veterinary health and innovative diagnostic devices, based in the United States, has selected Aiforia Technologies Plc as its partner for AI-assisted image analysis in animal samples. The total value of the contract is approximately USD 200 thousand.
“We're excited about this opportunity to participate in a mission to advance animal health and veterinarian success. This collaboration is yet another proof that Aiforia’s solutions for AI-powered image analysis cater to a broad range of applications in the medical field,” says Jukka Tapaninen, CEO of Aiforia.
Certified Adviser
UB Securities Ltd, tel. +358 9 25 380 225
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more: www.aiforia.com
Back to all blog posts
